Karah Herdman Parschauer - Net Worth and Insider Trading
Karah Herdman Parschauer Net Worth
The estimated net worth of Karah Herdman Parschauer is at least $3 Million dollars as of 2024-12-27. Karah Herdman Parschauer is the EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc and owns about 57,981 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $3 Million. Karah Herdman Parschauer is also the Director of Evolus Inc and owns about 31,243 shares of Evolus Inc (EOLS) stock worth over $354,608. Details can be seen in Karah Herdman Parschauer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karah Herdman Parschauer has not made any transactions after 2024-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karah Herdman Parschauer
Karah Herdman Parschauer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karah Herdman Parschauer owns 5 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Arcturus Therapeutics Holdings Inc (ARCT) , and Evolus Inc (EOLS) among others .
Click here to see the complete history of Karah Herdman Parschauer’s form 4 insider trades.
Insider Ownership Summary of Karah Herdman Parschauer
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2024-06-12 | EVP and General Counsel |
ARCT | Arcturus Therapeutics Holdings Inc | 2019-06-19 | director |
EOLS | Evolus Inc | 2024-01-30 | director |
2022-04-21 | director | ||
2021-12-22 | director |
Karah Herdman Parschauer Latest Holdings Summary
Karah Herdman Parschauer currently owns a total of 2 stocks. Among these stocks, Karah Herdman Parschauer owns 57,981 shares of Ultragenyx Pharmaceutical Inc (RARE) as of June 12, 2024, with a value of $3 Million and a weighting of 87.75%. Karah Herdman Parschauer also owns 31,243 shares of Evolus Inc (EOLS) as of January 30, 2024, with a value of $354,608 and a weighting of 12.25%.
Latest Holdings of Karah Herdman Parschauer
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2024-06-12 | 57,981 | 43.82 | 2,540,727 |
EOLS | Evolus Inc | 2024-01-30 | 31,243 | 11.35 | 354,608 |
Holding Weightings of Karah Herdman Parschauer
Karah Herdman Parschauer Form 4 Trading Tracker
According to the SEC Form 4 filings, Karah Herdman Parschauer has made a total of 19 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 9,806 shares on June 12, 2024, which brought Karah Herdman Parschauer around $441,270.
According to the SEC Form 4 filings, Karah Herdman Parschauer has made a total of 1 transactions in Evolus Inc (EOLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Evolus Inc is the sale of 11,931 shares on January 30, 2024, which brought Karah Herdman Parschauer around $156,773.
Insider Trading History of Karah Herdman Parschauer
- 1
Karah Herdman Parschauer Trading Performance
Karah Herdman Parschauer Ownership Network
Karah Herdman Parschauer Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Karah Herdman Parschauer is the EVP and General Counsel of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include director & 10 percent owner & President & CEO Emil D Kakkis , Chief Financial Officer Howard Horn , and Controller and PAO Theodore Alan Huizenga .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Karah Herdman Parschauer made 2 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 13,562. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 156,126 shares made by Emil D Kakkis , a net sale of 3,565 shares made by Theodore Alan Huizenga , and a net sale of 52,398 shares made by Thomas Richard Kassberg .
In summary, during the past 3 months, insiders sold 15,738 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 15,738 shares. During the past 18 months, 264,892 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 264,892 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Karah Herdman Parschauer Mailing Address
Above is the net worth, insider trading, and ownership report for Karah Herdman Parschauer. You might contact Karah Herdman Parschauer via mailing address: 60 Leveroni Court, Novato Ca 94949.